Efficacy of subsequent chemotherapy for patients with BRCA1/2-mutated recurrent epithelial ovarian cancer progressing on olaparib versus placebo maintenance: post-hoc analyses of the SOLO2/ENGOT Ov-21 trial, 2022, J.S. Frenel , J.W. Kim , N. Aryal , R. Asher , D. Berton , L. Vidal , et al. , Tomasz Huzarski(*) , S. Pignata , N. Colombo , Annals of Oncology, Vol. 33, Issue 10, 1021--1028, ISSN: 0923-7534, eISSN: 1569-8041, bibliogr. summ.
Słowa kluczowe: BRCA mutation, PARP inhibitor resistance, relapsing ovarian cancer
Kod: CZR-N-WYKAZ BibTeX (pkt. 200) DOI: 10.1016/j.annonc.2022.06.011

The impact of olaparib dose reduction and treatment interruption on treatment outcome in the SOLO2/ENGOT-ov21 platinum-sensitive recurrent ovarian cancer, 2022, K.E. Francis , S.I Kim , M. Friedlander , V. Gebski , Isabelle Ray-Coquard , Andrew Clamp , et al. , Tomasz Huzarski(*) , C. Martin Lorente , S.C. Cecere , et al. , Annals of Oncology, Vol. 33, Issue 6, 593--601, ISSN: 0923-7534, eISSN: 1569-8041, bibliogr. summ.
Słowa kluczowe: PARP inhibitors, adherence, adverse events, dosage, ovarian cancer, relative dose intensity
Kod: CZR-N-WYKAZ BibTeX (pkt. 200) DOI: 10.1016/j.annonc.2022.02.222

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer, 2022, Charles Edward Geyer , Judy E. Garber , Richard D. Gelber , [et. al] , Tomasz Huzarski(*) , OlympiA Clinical Trial SC and Investigators , [et. al] , Annals of Oncology, Vol. 33, 12, 1250--1268, ISSN: 0923-7534, eISSN: 1569-8041, bibliogr. tab. wykr.
Słowa kluczowe: BRCA1/2, PARP inhibition, adjuvant therapy, breast cancer, olaparib
Kod: CZR-N-WYKAZ BibTeX (pkt. 200) DOI: 10.1016/j.annonc.2022.09.159

Open Access: Licence: CC-BY, Article mode: OPEN_JOURNAL, Release time: AT_PUBLICATION, Text version: FINAL_PUBLISHED, Date of publication: 10-10-2022

Cancer effect on periprocedural thromboembolism and bleeding in anticoagulated patients, 2012, Alfonso J. Tafur , Waldemar E. Wysokiński , Robert McBane , Edyta Wolny-Rokicka , Edyta Sutkowska , S. C. Litin , P. R. Daniels , Joshua P. Slusser , David O. Hodge , John A. Heit , Annals of Oncology, Vol. 23, Iss. 8, 1998?-2005, ISSN: 0923-7534, eISSN: 1569-8041, bibliogr. summ.
Słowa kluczowe: bleeding, malignancy, periprocedural management of anticoagulation, thromboembolism
Kod: CZR-JCR BibTeX (pkt. 40) DOI: 10.1093/annonc/mds058